1 In an effort to minimize unnecessary disruptions to patient treatment, the FDA confirmed that it does not intend to take enforcement action against outsourcing facilities and compounders for violations of the Federal Food, Drug, and Cosmetic Act (FDCA) arising from conditions that depend on tirzepatide injection products inclusion on the FDAs drug shortage list, or for compounding, distributing, or dispensing tirzepatide injection products that are essentially a copy of Mounjaro and Zepbound, during the following periods: However, the FDA may still take action against these parties regarding violations of other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe for patients
Remote Pharmacy's platform, which delivers professional review, pharmacist fulfillment, and secure, HIPAA-compliant infrastructure, is instrumental in shaping the future of prescription-based weight management
Sustainable health doesnt come from the scale alone
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinsons disease
Indication and Usage Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of : 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Iqbal PM, Maadarani OS, Bitar ZI